Adaptive Biotechnologies (NASDAQ:ADPT) executives said the company delivered “remarkable” performance in 2025, driven by ...
Q3 2026 Earnings Call February 5, 2026 5:00 PM ESTCompany ParticipantsJason Starr - Head of Investor RelationVincent Pilette ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results